In this study, we measured the effect of an acute treatment of citalopram on 5-HT synthesis in a genetic rat model of depression, the Flinders Sensitive Line (FSL) rats, their counterparts, the Flinders Resistant Line (FRL) rats, and outbred Sprague-Dawley (SPD) rats, using the α-[ 14 C]methyl-Ltryptophan (α-MTrp) autoradiographic method. A comparison of 5-HT synthesis in the FSL rats treated with citalopram (FSL-CTP) and those treated with saline (FSL-SAL) indicate that citalopram reduces global 5-HT synthesis in the FSL rats, as well as in all the brain areas investigated. The reduced synthesis was also observed in the dorsal raphe nucleus (DR) and the median raphe nucleus (MR). The comparison of the synthesis between the citalopram treated SPD rats (SPD-CTP) and the saline treated SPD rats (SPD-SAL) revealed a global increase of 5-HT synthesis in the SPD-CTP group, as well as an increase in some terminal areas, but a reduction in the DR and the MR. In contrast to the reduction throughout the brain in the FSL rats, the FRL rats treated with citalopram (FRL-CTP), when compared to the saline group (FRL-SAL), showed a global increase of 5-HT synthesis, as well as in most of the terminal areas and in the DR and the MR. The reduction of 5-HT synthesis throughout the brain in the FSL rats is likely a result of reported supersensitivity of the 5-HT 1A receptors. Comparing changes in the SPD, FRL, and FSL rats treated with citalopram to their respective controls (saline treated rats), the FSL rats treated acutely with citalopram were the only rats that exhibited lower 5-HT synthesis rates in all of the limbic areas, the basal ganglia, and the neocortices. This may be related to the pathophysiological basis of depressive characteristics in FSL rats. The citalopram treatment produced unexpected results in the FRL rats: 5-HT synthesis was elevated not only in most of the terminal areas, but also in the cell body areas, the DR and MR. The increase of 5-HT synthesis throughout the brain in the FRL rats is likely a result of the reported subsensitivity of the 5-HT 1A receptors, and possibly other sites through which 5-HT synthesis could be controlled (e.g., 5-HT 1B ). In addition differences in intracellular signaling could be at least in part responsible for these differences. 4Correspondence to;